The Research Team at Tavros Therapeutics focuses on identifying and validating genetic targets for precision oncology therapies. Through rigorous experimentation and innovative methodologies, they analyze tumors' genetic vulnerabilities to develop small-molecule drug candidates. Their collaborative efforts contribute to advancing the company's pipeline and enhancing understanding of synthetic lethal interactions in cancer treatment.